Allocation of Recoveries. Any recoveries resulting from such legal action initiated by ▇▇▇▇▇ or Paragon hereunder relating to Patent Infringement or Patent Challenge in each case solely with respect to the Licensed Antibody Patents, including pursuant to a settlement, shall be applied as follows: (i) first to reimburse the [***] of each of the Parties in such action; and (ii) second, any amounts remaining after paying the amounts due each Party under clause (i) (the “Remaining Recovery”) shall be allocated as follows: (1) [***]; or (2) [***].
Appears in 2 contracts
Sources: License Agreement (Oruka Therapeutics, Inc.), Il 17 License Agreement (Oruka Therapeutics, Inc.)
Allocation of Recoveries. Any recoveries resulting from such legal action initiated by ▇▇▇▇▇ or Paragon hereunder relating to Patent Infringement or Patent Challenge in each case solely with respect to of the Licensed Antibody PatentsPatnets, including pursuant to a settlement, shall be applied as follows: (i) first to reimburse the [***] of each of the Parties in such action; and (ii) second, any amounts remaining after paying the amounts due each Party under clause (i) (the “Remaining Recovery”) shall be allocated as follows: (1) [***]; or (2) [***]..
Appears in 1 contract
Allocation of Recoveries. Any recoveries resulting from such legal action initiated by ▇▇▇▇▇ Apogee or Paragon hereunder relating to Patent Infringement or Patent Challenge in each case solely with respect to the Licensed Antibody Patents, including pursuant to a settlement, shall be applied as follows: (i) first to reimburse the [***] of each of the Parties in such action; and (ii) second, any amounts remaining after paying the amounts due each Party under clause (i) (the “Remaining Recovery”) shall be allocated as follows: (1) [***]; or (2) [***].
Appears in 1 contract
Allocation of Recoveries. Any recoveries resulting from such legal action initiated by ▇▇▇▇▇ Crescent or Paragon hereunder relating to Patent Infringement or Patent Challenge in each case solely with respect to of the Licensed Antibody Patents, including pursuant to a settlement, shall be applied as follows: (i) first to reimburse the [***] of each of the Parties in such action; and (ii) second, any amounts remaining after paying the amounts due each Party under clause (i) (the “Remaining Recovery”) shall be allocated as follows: (1) [***]; or (2) [***].
Appears in 1 contract
Allocation of Recoveries. Any recoveries resulting from such legal action initiated by ▇▇▇▇▇ Spyre or Paragon hereunder relating to Patent Infringement or Patent Challenge in each case solely with respect to the Licensed Antibody Patents, including pursuant to a settlement, shall be applied as follows: (i) first to reimburse the [***] of each of the Parties in such action; and (ii) second, any amounts remaining after paying the amounts due each Party under clause (i) (the “Remaining Recovery”) shall be allocated as follows: (1) [***]; or (2) [***].
Appears in 1 contract